➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Express Scripts
Mallinckrodt
McKesson
Harvard Business School

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Chlorhexidine gluconate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for chlorhexidine gluconate and what is the scope of patent protection?

Chlorhexidine gluconate is the generic ingredient in twenty-eight branded drugs marketed by Xttrium, Sage Prods, Medline Industries, Bajaj, Hi Tech Pharma, Lyne, Pharm Assoc, Wockhardt Bio Ag, Sunstar Americas, 3M, Colgate Palmolive Co, Colgate-palmolive Co, Soapco, Ecolab, Molnlycke Hlth, J And J, Matrix Medcl, Griffen, Becton Dickinson, Kendall Il, Carefusion 2200, Dexcel Pharma, 3m Health Care, Becton Dickinson Co, and Prof Dspls, and is included in thirty-six NDAs. There are twelve patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Chlorhexidine gluconate has three patent family members in one country.

There are fifty-eight drug master file entries for chlorhexidine gluconate. Fifty-five suppliers are listed for this compound.

Drug Prices for chlorhexidine gluconate

See drug prices for chlorhexidine gluconate

Drug Sales Revenue Trends for chlorhexidine gluconate

See drug sales revenues for chlorhexidine gluconate

Recent Clinical Trials for chlorhexidine gluconate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, San FranciscoPhase 2
University of Wisconsin, MadisonPhase 4
Zagazig UniversityPhase 1/Phase 2

See all chlorhexidine gluconate clinical trials

Pharmacology for chlorhexidine gluconate
Physiological EffectDecreased Cell Wall Integrity
Medical Subject Heading (MeSH) Categories for chlorhexidine gluconate
Paragraph IV (Patent) Challenges for CHLORHEXIDINE GLUCONATE
Tradename Dosage Ingredient NDA Submissiondate
HIBICLENS SPONGE;TOPICAL chlorhexidine gluconate 018423

US Patents and Regulatory Information for chlorhexidine gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J MICRODERM chlorhexidine gluconate SPONGE;TOPICAL 072295-001 Feb 28, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Bajaj CHLORHEXIDINE GLUCONATE chlorhexidine gluconate SOLUTION;TOPICAL 020111-001 Sep 11, 1997 OTC No No   Start Trial   Start Trial   Start Trial
Colgate Palmolive Co PERIOGARD chlorhexidine gluconate SOLUTION;DENTAL 073695-001 Jan 14, 1994 AT RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for chlorhexidine gluconate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dexcel Pharma PERIOCHIP chlorhexidine gluconate TABLET;DENTAL 020774-001 May 15, 1998   Start Trial   Start Trial
Molnlycke Hlth HIBICLENS chlorhexidine gluconate SOLUTION;TOPICAL 017768-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
Molnlycke Hlth HIBICLENS chlorhexidine gluconate SPONGE;TOPICAL 018423-001 Approved Prior to Jan 1, 1982   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Dow
Express Scripts
Mallinckrodt
McKesson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.